Procurement Summary
Country : Canada
Summary : Supply of ICP-MS device for Ac-225 production
Deadline : 17 Jan 2020
Other Information
Notice Type : Tender
TOT Ref.No.: 39203037
Document Ref. No. : P476-ICPMS-1219
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : TRIUMF
Chu, Kai-Mei Procurement ManagerTRIUMFProcurement4004 Wesbrook MallVancouver, British ColumbiaV6T 2A3 Phone: 1 (604) 2227422
Canada
Email :kaimei@triumf.ca
Tender Details
Actinium-225 (225ac) is a therapeutic radionuclide with a demonstrated ability to effectively treat late-stage cancers. Despite this potential, the current global demand for 225ac far exceeds the available supply of approximately 74 gbq (2 ci).
triumf project-476 (p476) will enable triumf to implement 225ac production technologies developed under its experimental programs into a routine operation that safely produces an 225ac product meeting current industry standards of quality at a scale comparable to all other current major 225ac producers. P476 will accomplish this by leveraging the results of experimental efforts such as l124 and l125, and by further adding additional infrastructure, equipment, processes, and procedures to triumf's 225ac production capabilities.
a critical component of p476 is the completion of quality control deliverables that will provide triumf with the capabilities to ensure 225ac produced by p476 meets product specifications. These quality control deliverables include analytical devices and the development and validation of quality control protocols.
43136883 -- needed for pdf -- needed for pdf -- needed for pdf -- needed for pdf -- needed for pdf -- needed for pdf--
Closing Date and Time : 2020/01/17 14:00
Documents
Tender Notice